Zymeworks Inc.
IPOMaking a Meaningful Difference — Zymeworks
Public · $65.0M raised
- Business Model
- B2B
- Website
- zymeworks.com
- Total Funding
- $65.0M
- Last Round
- $61.5M Venture RoundJan 2015
- Rounds
- 2
- Type
- Public
About
Royalty-driven biotechnology company developing novel multifunctional medicines for difficult-to-treat cancers and serious diseases.
Summary
Zymeworks Inc. is a Biotech company. It has raised $65.0M in total across 2 rounds, most recently a $61.5M Venture Round round in Jan 2015. Investors include Royalty Pharma and BDC Venture Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...